Stockscreener 앱 받기
3.62
1.40%
0.05
시간 외 거래:
3.67
0.05
+1.38%
전일 마감가:
$3.57
열려 있는:
$3.57
하루 거래량:
3.65M
Relative Volume:
0.74
시가총액:
$1.08B
수익:
$38.03M
순이익/손실:
$-146.40M
주가수익비율:
-6.9615
EPS:
-0.52
순현금흐름:
$-121.38M
1주 성능:
-1.09%
1개월 성능:
-36.04%
6개월 성능:
+83.76%
1년 성능:
+22.71%
1일 변동 폭
$3.49
$3.6799
1주일 범위
$3.33
$3.83
52주 변동 폭
$1.8906
$6.515
앱셀레라바이오로직스 Stock (ABCL) Company Profile
명칭
Abcellera Biologics Inc
전화
(604) 559-9005
주소
150 W 4TH AVENUE, VANCOUVER
ABCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
3.62 | 1.07B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
앱셀레라바이오로직스 Stock (ABCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-07-07 | 재개 | Leerink Partners | Outperform |
| 2024-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-02-22 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-10-13 | 재개 | Piper Sandler | Overweight |
| 2023-02-28 | 개시 | Cowen | Outperform |
| 2022-12-15 | 개시 | Goldman | Buy |
| 2022-11-16 | 개시 | Truist | Buy |
| 2021-12-21 | 개시 | The Benchmark Company | Buy |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2021-01-05 | 개시 | Berenberg | Buy |
| 2021-01-05 | 개시 | Credit Suisse | Outperform |
| 2021-01-05 | 개시 | SVB Leerink | Outperform |
| 2021-01-05 | 개시 | Stifel | Buy |
모두보기
앱셀레라바이오로직스 주식(ABCL)의 최신 뉴스
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss - Insider Monkey
AbCellera Biologics Inc. (ABCL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How AbCellera Biologics Inc. (8QQ) stock correlates with oil marketsJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Is AbCellera Biologics Inc a good long term investmentStock Price Targets & Low Risk Wealth Building - earlytimes.in
Is AbCellera Biologics Inc. (8QQ) stock safe for risk averse investors2025 Fundamental Recap & AI Driven Stock Reports - newser.com
How AbCellera Biologics Inc. (8QQ) stock compares with market leadersJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Will AbCellera Biologics Inc. (8QQ) stock outperform energy sector in 2025Market Trend Summary & High Conviction Buy Zone Alerts - newser.com
How AbCellera Biologics Inc. (8QQ) stock reacts to weak economy2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
Is AbCellera Biologics Inc. (8QQ) stock at risk of policy regulationJobs Report & Daily Entry Point Alerts - newser.com
Can AbCellera Biologics Inc. (8QQ) stock resist broad market declinesMarket Volume Report & Accurate Intraday Trade Tips - newser.com
AbCellera Biologics’ Earnings Call: Key Insights - MSN
How AbCellera Biologics Inc. stock reacts to Fed rate cutsAnalyst Upgrade & Expert Curated Trade Setups - newser.com
Is a relief rally coming for AbCellera Biologics Inc. holdersDollar Strength & Fast Gain Stock Trading Tips - newser.com
What’s next for AbCellera Biologics Inc. stock priceQuarterly Investment Review & Capital Efficient Trade Techniques - newser.com
Will AbCellera Biologics Inc. stock reach Wall Street targetsWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com
What makes AbCellera Biologics Inc. (8QQ) stock appealing to growth investors2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Is AbCellera Biologics Inc. (8QQ) stock considered safe haven2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Is AbCellera Biologics Inc. (8QQ) stock dividend growth reliableMarket Sentiment Summary & High Return Trade Opportunity Guides - newser.com
Why AbCellera Biologics Inc. (8QQ) stock stays on buy listsQuarterly Investment Review & Low Risk Investment Opportunities - newser.com
Real time breakdown of AbCellera Biologics Inc. stock performanceDollar Strength & Safe Investment Capital Preservation Plans - newser.com
Will AbCellera Biologics Inc. stock maintain momentum in 2025Weekly Gains Summary & Safe Entry Point Identification - newser.com
Will AbCellera Biologics Inc. (8QQ) stock hit Wall Street targetsAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will AbCellera Biologics Inc. see short term momentum2025 Top Decliners & AI Driven Stock Reports - newser.com
앱셀레라바이오로직스 (ABCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
1.88%
자본화:
|
볼륨(24시간):